未登录Novel framework for response evaluation criteria in grade 1/2 neuroendocrine tumors (RECIN) following [177Lu]Lu-DOTATATE therapy: post-hoc analysis of the phase 2 LuCAP trial新型框架：用于[177Lu]Lu-DOTATATE疗法后1/2级神经内分泌肿瘤（RECIN）的治疗反应评估标准——LuCAP 2期试验的事后分析
Satapathy, Swayamjeet; Aggarwal, Piyush; Sood, Ashwani; Chandekar, Kunal R.; Das, Chandan K.; Gupta, Rajesh; Khosla, Divya; Das, Namrata; Kapoor, Rakesh; Kumar, Rajender; Singh, Harmandeep; Mittal, Bhagwant R. .png)
分享.png)
收藏177Lu-DOTATATE Plus Capecitabine Versus 177Lu-DOTATATE Alone in Patients with Advanced Grade 1/2 Gastroenteropancreatic Neuroendocrine Tumors (LuCAP): A Randomized, Phase 2 Trial177Lu-DOTATATE联合卡培他滨与177Lu-DOTATATE单药治疗晚期G1/G2级胃肠胰神经内分泌肿瘤（LuCAP）：一项随机、Ⅱ期临床试验Satapathy, Swayamjeet; Aggarwal, Piyush; Sood, Ashwani; Chandekar, Kunal R.; Das, Chandan K.; Gupta, Rajesh; Khosla, Divya; Das, Namrata; Kapoor, Rakesh; Kumar, Rajender; Singh, Harmandeep; Shukla, Jaya; Kumar, Ajay; Mittal, Bhagwant Rai 分享 收藏 Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III TrialPrabhash, Kumar; Deshmukh, Chetan; Malhotra, Hemant; Sharma, Atul; Jain, Minish; Dhamne, Nilesh; Nagarakar, Rajnish; Ganesan, Prasantha; Mahobia, Vijay K.; Das, Chandan K.; Kumar, Rejnish; Shivanna, Prakash S.; Avaronnan, Manu P.; Chaithanya, Puligundla K.; Chaudhary, Vaibhav; Singh, Kartar; Aagre, Suhas; Ravishankar, Bellala; Mehta, Dhruv; Shilpa, Kandipalli; Maniar, Vashishth; Chatterjee, Koushik; Majumdar, Saroj D.; Dana, Rohitashwa; Noronha, Vanita; Menon, Nandini; Sharma, Akhilesh; Pawar, Roshan; Shahavi, Vinayaka; Yadav, Rajiv; Aiwale, Amol 分享 收藏 Aflatoxin exposure is associated with an increased risk of gallbladder cancerYadav, Amit; Gupta, Pankaj; Gupta, Parikshaa; Patil, Amol N.; Das, Chandan K.; Hooda, Harish; Thakur, Deepa; Sharma, Vishal; Singh, Anupam K.; Yadav, Thakur Deen; Kaman, Lileswar; Thakur, Jarnail Singh; Sudini, Hari Kishan; Srinivasan, Radhika; Dutta, Usha 分享 收藏 Safety and Efficacy of 177Lu-DOTATATE in Children and Young Adult PopulationAggarwal, Piyush; Satapathy, Swayamjeet; Sood, Ashwani; Singh, Harmandeep; Mittal, Bhagwant Rai; Lal, Sadhna; Gupta, Rajesh; Das, Chandan Krushna; Yadav, Thakur Deen; Walia, Rama 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 NSD2 is a requisite and targetable subunit of the AR/FOXA1 neo-enhanceosome complex in prostate cancer cellsParolia, Abhijit; Verma, Brijesh K.; Eyunni, Sanjana; Aras, Sweta; Carson, Sandra E.; Young, Eleanor; Das, Chandan K.; George, James M.; Rasool, Reyaz ur; Gajjala, Prathibha; Alhusayan, Mohammed; Mitchell-Velasquez, Erick; Xiao, Lanbo; Luo, Jie; Jaber, Mustapha; Cao, Xuhong; Su, Fengyun; Wang, Rui; Liu, Lianchao; Wang, Zhen; Ding, Ke; Chinnaiyan, Arul M.; Asangani, Irfan 分享 收藏 Randomized crossover trial of 'Roll-over' technique of abdominal paracentesis versus standard technique in suspected malignant ascites在可疑的恶性腹水中，腹部穿刺术的 “翻滚” 技术与标准技术的随机交叉试验Jha, Daya Krishna; Rohilla, Manish; Das, Chandan K.; Irrinki, Santhosh; Singh, Harjeet; Arora, Aashima; Saha, Subhas C.; Gupta, Pankaj; Mandavdhare, Harshal S.; Dutta, Usha; Sharma, Aman; Sharma, Vishal 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 177Lu-PSMA-617 versus docetaxel in chemotherapy-naive metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trialSatapathy, Swayamjeet; Mittal, Bhagwant Rai; Sood, Ashwani; Das, Chandan Krushna; Mavuduru, Ravimohan Suryanarayan; Goyal, Shikha; Shukla, Jaya; Singh, Shrawan Kumar 分享 收藏 分享 收藏 分享 收藏 'Rollover' abdominal paracentesis versus standard technique: protocol of a crossover randomized comparative trialSharma, Vishal; Jha, Daya Krishna; Rohilla, Manish; Das, Chandan K.; Singh, Harjeet; Irrinki, Santhosh; Arora, Aashima; Saha, Subhas C.; Gupta, Pankaj; Mandavdhare, Harshal S.; Dutta, Usha; Sharma, Aman 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
